Epigenomics, Inc: Clinical Trials

12 trials sponsored by Epigenomics, Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 unknown, 1 withdrawn. 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Not applicable1Completed 1

Follow Epigenomics, Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Plasma-based Colorectal Cancer Screening Research & Development
Epi proColon - Colo-rectal Cancer
CompletedEpigenomics, Inc3542019-05-032021-02-02
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
Cirrhosis, Liver, Hepatic Cirrhosis
CompletedEpigenomics, Inc1752018-12-172020-01-30
Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis
"Epi proColon 2.0 CE" test from Epigenomics, Inc (Berlin, Germany) - Hepatocellular Carcinoma, Cirrhosis
Not applicableCompletedCentral Hospital, Nancy, France6392018-02-122026-06-10
Longitudinal Performance of Epi proColon
Epi proColon - Colorectal Cancer, Colorectal Neoplasms
UnknownEpigenomics, Inc45002017-08-182021-11-01
Adherence to Minimally Invasive Testing
Epi proColon Test, Fecal Immunochemical Test (FIT) - Colorectal Cancer
CompletedEpigenomics, Inc4902014-10-012015-06-30
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
Epi proColon Testing - Familial Adenomatous Polyposis, Map Syndrome
CompletedUniversity of Pennsylvania242014-07-012019-08-28
Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test
Colorectal Cancer
WithdrawnEpigenomics, Inc2012-06-012014-08-04
Head to Head Study Epi proColon and FIT
Colorectal Cancer
CompletedEpigenomics, Inc3362012-03-012015-08-04
Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging
No intervention - Lung Cancer With Mediastinal Lymph Node Involvement
CompletedUniversity Hospital, Essen2002012-02-012016-10-26
Specimens for Septin 9 Performance
Blood Sample - Colorectal Cancer
Early Phase 1CompletedEpigenomics, Inc5622011-05-012014-08-04
PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
All eligible subjects will provide blood for SEPT9 biomarker testing - Colorectal Cancer
CompletedEpigenomics, Inc79292008-06-012014-08-04
Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Colorectal Cancer
CompletedEpigenomics, Inc7002005-01-012008-06-17

Conditions studied

Colorectal Neoplasms (8)  ·  Carcinoma, Hepatocellular (2)  ·  Adenomatous Polyposis Coli (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (1)  ·  Fibrosis (1)  ·  Genetic Diseases, Inborn (1)  ·  Liver Cirrhosis (1)  ·  Liver Neoplasms (1)  ·  Lung Neoplasms (1)

Interventions

Blood Specimen Collection (2)  ·  Biomarkers (1)  ·  DNA Methylation (1)

Countries

United States (8)  ·  Germany (3)  ·  France (1)  ·  Hungary (1)  ·  Puerto Rico (1)

Top investigators

Amanda Petrik (1)  ·  Bryson Katona, MD (1)  ·  Catherine Lofton-Day, PhD (1)  ·  David F Ransohoff, MD (1)  ·  Gloria Coronado, PhD (1)  ·  Juergen Beck, MD (1)  ·  Michael Wandell, PharmD. (1)  ·  Neil Mucci (1)  ·  Nick Potter (1)  ·  Theo DeVos (1)  ·  Timothy R Church, Ph.D. (1)

Results publications

PMID 23408352, PMID 24333512, PMID 24901436, PMID 33765926